"Nous vous prenons en charge pour vos soins oncologiques. Nos professionnels disposent de matériel de haute technologie pour vos traitements de chimiothérapie et de radiothérapie. Nous vous proposons des consultations avant et après le traitement pour vous accompagner de façon personnalisée. Pour plus d'informations, consultez notre site internet."

During the past decade, Hopital Caremeau; Hematologie Oncologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Caremeau; Hematologie Oncologie" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Caremeau; Hematologie Oncologie" are "Breast Cancer" (1 trials), "Follicular Lymphoma" (1 trials), "Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hopital Caremeau; Hematologie Oncologie" in a lesser frequency.

Most popular intervention types in "Hopital Caremeau; Hematologie Oncologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Bosutinib" (1 trials), "Imatinib" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Caremeau; Hematologie Oncologie" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Caremeau; Hematologie Oncologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hopital Caremeau; Hematologie Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Caremeau; Hematologie Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".